Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04199949
Other study ID # A90355
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date March 1, 2020

Study information

Verified date February 2022
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Physical inactivity is a significant predictor of major non-communicable diseases such as type 2 diabetes (7%), cardiovascular disease (6%), musculoskeletal disorders and some types of cancer, and has been proposed to be the 4th leading cause of death worldwide. The investigators aim is to assess the vascular (endothelial) function before and after a 5-day period of reduced activity of upper and lower limbs via an arm sling and daily step counts reduction, respectively, in healthy participants. Twelve young (ages of 18 - 35 years), healthy, males and females, recreationally active with a body mass index between 18 and 27 kg/m2 will be recruited. The participants will then randomly undergo two 5-day interventions: (A) 5 consecutive days of habitual daily levels of physical activity and matched food intake (Control trial). (B) 5 consecutive days of reduced step count by 80% compared to the Control trial combined with their non-dominant arm placed in a sling and a reduction in food (energy) intake (~20%) to match the reduction in energy expenditure induced by inactivity (Inactivity trial). On days 1 and 6 of each experimental trial, the endothelial function of the brachial and popliteal arteries, and hand grip strength will be measured.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date March 1, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Non-smoking - Males - Age (18-35 years old) - Body mass index (BMI) of 18-27 kg/m2 - Recreationally active - Ability to give informed consent Exclusion Criteria: - Smoking - Any metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism) or cardiovascular (e.g. heart or blood) abnormalities including hypertension or heart failure - Clinically significant abnormalities on screening including ECG abnormalities - Taking routine medication that may alter cardiovascular function and blood flow (e.g. blood pressure-lowering drugs or drugs that cause hypertension) - Well-trained individuals - On an energy-restricted diet or seeking to lose weight - High alcohol consumption (<3-4 units/day)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Inactivity
On days 1 and 6 of each main trial, the participants will be asked to attend the laboratory after an overnight fast of at least 8 to 12h to undergo brachial and popliteal arteries FMD measurements (30 min apart) using duplex-Doppler ultrasound, followed by assessment of the hand grip strength of their non-dominant hand using a hand dynamometer.

Locations

Country Name City State
United Kingdom The University of Nottingham Nottingham Nottinghamshire

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of flow-mediated vasodilatation (FMD) of the brachial artery The FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm
Primary Change from baseline of flow-mediated vasodilatation (FMD) of the popliteal artery The FMD of the popliteal artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm
Secondary Hand grip strength The hand grip strength will be measured using a hand dynamometer. Three maximum hand grips separated by one minute rest at the end of each visit. 3 minutes
See also
  Status Clinical Trial Phase
Completed NCT02127333 - Role of Oxygen for Vascular Dysfunction N/A
Completed NCT05857085 - Novel Therapeutics and Endothelial Dysfunction in T1DM Patients Phase 4
Recruiting NCT05747924 - Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) Phase 1/Phase 2
Completed NCT01862146 - Arterial Remodeling in Smokers N/A